enVVeno Medical Corp

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

NVNO

organization

SIC: 3841

SEC Insider

$5.5M

141 transactions

Summary

enVVeno Medical Corp (NVNO) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $571KSales: $1.7M12 insiders

Date	Insider	Type	Value
2024-12-31	Duhay Francis	Buy	$250K
2024-12-19	BERMAN ROBERT ANDREW(Chief Executive Officer)	Buy	$31K
2024-12-19	Jenusaitis Matthew	Buy	$24K
2024-12-24	Shrivastava Sanjay	Buy	$16K
2024-12-31	Gray Robert	Buy	$10K
2025-09-15	Duhay Francis	Sell	$4K
2025-12-11	Duhay Francis	Sell	$2K
2026-03-12	Duhay Francis	Sell	$2K
2026-06-11	Duhay Francis	Sell	$1K
2025-12-16	Glickman Marc H.(SVP & Chief Medical Officer)	J	$0
2025-12-16	Alavi Hamed(Chief Technology Officer)	J	$0
2025-12-16	BERMAN ROBERT ANDREW(Chief Executive Officer)	J	$0
2025-12-11	Shrivastava Sanjay	A	$0
2025-12-11	Jenusaitis Matthew	A	$0
2025-12-11	Gray Robert	A	$0
2025-12-11	Duhay Francis	A	$0
2025-05-19	Bright Jennifer(Chief Financial Officer)	A	$0
2024-12-18	Duhay Francis	A	$0
2024-12-18	Alavi Hamed(Chief Technology Officer)	A	$0
2024-12-18	Glickman Marc H.(SVP & Chief Medical Officer)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

enVVeno Medical Corp — Contributions, Lobbying & Contracts | Poliscope